Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - CHANGE IN WORKING CAPITAL
Change in Working Capital ELVN - Enliven Therapeutics, Inc.
1.4 M
LAST VALUE
-37.33%
2 YEAR CAGR
2.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR